Ministry of Health to address the issue of antibiotic resistance in its through the SEE Health Network (SEEHN) designated Regional Health Development Center (RHDC).
The RHDC is hosted by the National Centre of Infectious and Parasitic Diseases (NCIPD) which is under the Ministry of Health. It builds on the existing institutional, human and technical resources of the NCIPD in line with the Memorandum of Understanding on the future of the SEEHN and the plan for establishment and development of the RHDCs in the SEEHN member states.
The purpose of the event was to bring together all focal points on
antibiotic resistance of the 10 SEEHN member-states and to convene a 1,5 days discussions
on the most important issue of antibiotic resistance surveillance in the SEE region. The meeting was also attended by a
representative of Turkey
as an affiliated to the SEEHN for this special meeting. The National Centre of Infectious and Parasitic Diseases used to have a long standing collaboration with the Public Health Institute of
Turkey and their participation was valuable and beneficial for the future partnerships
of the RHDC.The meeting was also attended by the
representatives of some of the regions in Bulgaria who participate in the
national BULSTAR surveillance system of AMR.
During this first meeting, the participants
(focal points on antibiotic resistance of the 9 SEEHN countries) together with
the nationals from the regions had the opportunity to discuss different
important issues and problems faced by the countries and related to future plan
of work of the SEEHN RHDC on antibiotic resistance. The participants received a disc with all important official
documents related to the establishment and functioning of the SEEHN: MoU,
Decision on the establishment of RHDCs and Host Agreement.
A special
Questionnaire - SELF-ASSESSMENT SURVEY ON ANTIMICROBIAL RESISTANCE was prepared by the SEE RHDC in advance
and sent to all focal points. The questionnaire was based on the WHO EURO
documents and builds upon the strategic
objectives of the European Strategic Action Plan on Antimicrobial Resistance. The data received have been processed
by the SEE RHDC, reported and discussed during the meeting. Some recommendations
for further implementation of the objectives of the European Strategic Action
Plan on Antimicrobial Resistance have been made.
The most significant 5 bacterial pathogens in
hospitals in the region are: Klebsiella pneumoniae, Pseudomonas aeruginosa,
Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli, Enterococcus faecium; and in ambulatory
care are: Escherichia coli, Staphylococcus aureus , Streptococcus pneumonia,
Klebsiella pneumoniae, Enterococcus
faecium.
The main causes of drug resistance were
determined as overuse
of antibiotics, use of drugs without reasonable indications, inadequate
infection control and stewardship of antibiotic use in health care settings,
insufficient practical education on antibiotic use during undergraduate
education, uncontrollable use of antibiotics in animal sector, imperfect
laboratory diagnosis, lack of adequate therapeutic guides, lack of awareness of
the general population, inappropriate dose
and duration of treatment and the absence of systematic monitoring of drug use
in the medical, veterinary and food industries.
All
countries have national focal point for antimicrobial resistance. Only three of
them (Croatia , Macedonia and Montenegro ) have functional
national coordinating committee on antimicrobials/AMR. All countries
have reference laboratories. BiH Federation/BIH and the Republic of Moldova are in process of
establishment. There are reports for MRSA, carbapenemases,
PNSSP, VRE, but not for ESBL in 3 countries (Croatia ,
Republic of Moldova and the Republic of Serbia ).
All countries use for detection of AMR
phenotype methods, determination of MIC and genetic methods.
Most countries celebrate the
European Antibiotic Awareness Day. They have different activities. In all
countries doctors, hospital health care workers, community health care workers
have some education on AMR, as part of their general education, but there isn’t
enough specific educational programs in this field.
The experience of Bulgaria:
The Antibiotic Resistance Surveillance System
in Bulgaria BULSTAR which started in 1997 was
discussed on a large scale, with emphasis on the standardization of
laboratory methods through internal and external quality assessment system,
monitored materials from in-patient and out-patient health establishments, most
frequently isolated microorganisms in different materials, etc.
The resistance to 30 antibiotics is reported
annually on central level to the central reference laboratory of the National Center
on Infectious and Parasitic Diseases. The system covers the whole territory of
the country comprising of 166 microbiological labs. Out of 38 505 hospital beds
the system covers 22 812 hospital beds. 70 private labs are also participating
in the system, responsible for out-patient health establishments. The data
received are supportive for developing therapeutic guidelines and hospital
policies for coping with antibiotic resistance. The pharmaceutical companies in
Bulgaria
also use these data.
Although the antibiotic consumption in Bulgaria
for 2008-2010 is 24,6-22,5 DDDs per 1000 population per day, the antibiotic
resistance is increasing. The main reason for this is the overuse and misuse of
cephalosporin’s followed by penicillin’s alone and in combination with
inhibitors. Resistance to Gram-negative bacteria such as Escherichia coli and Klebsiella
pneumonia is rapidly increasing in Bulgaria too. During the last five
years the production of ESBLs has doubled in hospital settings. Resistance to
methicillin by Staphylococcus aureus
(MRSA) in total is 10% while the invasive resistance is much higher. The issue
of reduction in the prevalence of antibiotic resistance by addressing the use,
overuse and misuse of antibiotics in all sectors such as: health care,
veterinary and agricultural settings, etc. is also a priority for Bulgaria .
Preliminary discussions on inter-sectorial level have been carried out but the
results are not promising.
The presentations given by the Focal Points of
Bosnia and Herzegovina, Croatia, Israel, Montenegro, republic of Macedonia, Republic of Moldova and the Republic of Serbia on the current situation of AMR delineated
some interesting and debatable issues characteristic for all countries: policy
development, updating of legislation, networking, establishment of
inter-sectorial coordination mechanism at ministerial level, improvement of
communication between sectors, rational use of antibiotics, standardization of
methods, internal and external quality assessment systems, data management,
training of professionals and capacity building in management, lack or
insufficient guidelines in some countries, surveillance system in one country
(Montenegro) not in place, growing awareness to nosocomial infections, high
expenses of some tests and related financial pressure posed on microbiologists
from hospital directors, streamlining of expenses, overuse of broad specter
antibiotics related to some extend to their lower price compared to narrow
specter antibiotics (first and second generation cephalosporin’s), involvement
of private sector on larger scale, targeting general public on permanent basis,
constant awareness campaigns for different target groups,
The representative of Turkey also gave a short
presentation. Turkey started their surveillance system of antibiotic resistance
three years ago. They have approximately the same problems as the SEEHN
member-states. They are eager to share their data during the next meeting of
the Network.
During the meeting the following topics
associated with antibiotic resistance surveillance system, introduced by the Bulgarian professionals of the RHDC, were discussed by participants:
·
Communicable disease
surveillance system in Bulgaria· Epidemiology and antifungal susceptibility of clinically significant fungi
· Advances in molecular surveillance of healthcarе associated infections in Bulgaria
· Phenotypic methods for routine detection of antibiotic resistance mechanisms in Gram negative bacteria: the experience of a cancer hospital in Bulgaria
· Antimicrobial susceptibility of human extra-intestinal non-typhoid Salmonella isolates in Bulgaria, 2005-2012
· Current and emerging mechanisms of antimicrobial resistance in Bulgaria
· TB Surveilance in Bulgaria
· Characterization of methicillin-resistant Staphylococcus aureus isolated in Bulgaria
· The relationship between antibiotic consumption and antimicrobial drug resistance - general concepts
· COMBACTE network and research opportunities on the Balkans
In some countries like Israel the
specialization differs for doctors and biologists which is the American model.
In Europe it is different. The specialty of clinical immunology was also raised
and information exchanged.
The participants of the meeting reached a
common opinion that the establishment of an inter-sectorial coordinating
mechanism for antibiotic resistance surveillance at ministerial level is
essential.
The possibilities for collaboration and future
work have been discussed at the end of the meeting, namely:
- Approaching
TAIEX on behalf of Macedonia or eventually another SEEHN country for organizing
the next meeting of the Focal Points of RHDC based on the Draft Decision on the collaboration between SEEHN and EC/TAIEX in
2014 approved during the 32nd
Plenary Meeting of the SEE Health Network in Podgorica, Montenegro, November
2013.
- Mutual work of all member-states for preparation of educational programs for medical doctors, hospital health care workers, and community health care workers.
No comments:
Post a Comment